Zylox-Tonbridge Showcases Innovation Pipeline at Investor Open Day-To The Moon - Tiger Brokers Online Investing Community - To The Moon

Like
Comment
Favorite

Zylox-Tonbridge Showcases Innovation Pipeline at Investor Open Day

Reuters01-12

Zylox-Tonbridge Showcases Innovation Pipeline at Investor Open Day

Zylox-Tonbridge Medical Technology Co., Ltd. recently hosted an Investor Open Day at its Zhuhai Innovation Center, welcoming nearly 150 institutional investors and sell-side analysts. The event showcased the company’s innovation pipeline, including its image-guided endovascular therapy platform and the ZYLOX Pantheris™ atherectomy catheter. Management highlighted strategies for global growth, emphasizing R&D-driven innovation, global manufacturing, and expanding international commercialization. By the end of 2025, Zylox-Tonbridge products had been used in over one million procedures, and the company had established commercial coverage in 83 countries and regions.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Zylox-Tonbridge Medical Technology Co .Ltd. published the original content used to generate this news brief via PR Newswire (Ref. ID: CN60761) on January 12, 2026, and is solely responsible for the information contained therein.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Like

Report

Comment

empty

No comments yet

Most Discussed

7x24

{"i18n":{"language":"en_US"},"data":{"share":"https://ttm.financial/m/news/2602560457?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-01-12 12:16","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2602560457","market":"nz","top_or_hot":-1,"title":"Zylox-Tonbridge Showcases Innovation Pipeline at Investor Open Day","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      Zylox-Tonbridge Showcases Innovation Pipeline at Investor Open Day\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        Zylox-Tonbridge Medical Technology Co., Ltd. recently hosted an Investor Open Day at its Zhuhai Innovation Center, welcoming nearly 150 institutional investors and sell-side analysts. The event showcased the company’s innovation pipeline, including its image-guided endovascular therapy platform and the ZYLOX Pantheris™ atherectomy catheter. Management highlighted strategies for global growth, emphasizing R&amp;D-driven innovation, global manufacturing, and expanding international commercialization. By the end of 2025, Zylox-Tonbridge products had been used in over one million procedures, and the company had established commercial coverage in 83 countries and regions.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n<i>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Zylox-Tonbridge Medical Technology Co .Ltd. published the original content used to generate this news brief via PR Newswire (Ref. ID: CN60761) on January 12, 2026, and is solely responsible for the information contained therein.</span></i>\n</p>\n</div></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Zylox-Tonbridge Showcases Innovation Pipeline at Investor Open Day</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nZylox-Tonbridge Showcases Innovation Pipeline at Investor Open Day\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2026-01-12 12:16</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      Zylox-Tonbridge Showcases Innovation Pipeline at Investor Open Day\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        Zylox-Tonbridge Medical Technology Co., Ltd. recently hosted an Investor Open Day at its Zhuhai Innovation Center, welcoming nearly 150 institutional investors and sell-side analysts. The event showcased the company’s innovation pipeline, including its image-guided endovascular therapy platform and the ZYLOX Pantheris™ atherectomy catheter. Management highlighted strategies for global growth, emphasizing R&amp;D-driven innovation, global manufacturing, and expanding international commercialization. By the end of 2025, Zylox-Tonbridge products had been used in over one million procedures, and the company had established commercial coverage in 83 countries and regions.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n<i>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Zylox-Tonbridge Medical Technology Co .Ltd. published the original content used to generate this news brief via PR Newswire (Ref. ID: CN60761) on January 12, 2026, and is solely responsible for the information contained therein.</span></i>\n</p>\n</div></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK1587","symbol_name":"次新股","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260112:nNDL3GpywB:1","article_id":"2602560457","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2602560457","pubTimestamp":1768191419,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"Zylox-Tonbridge Medical Technology Co., Ltd. recently hosted an Investor Open Day at its Zhuhai Innovation Center, welcoming nearly 150 institutional investors and sell-side analysts. The event showcased the company’s innovation pipeline, including its image-guided endovascular therapy platform and the ZYLOX Pantheris atherectomy catheter. Management highlighted strategies for global growth, emphasizing R&D-driven innovation, global manufacturing, and expanding international commercialization. By the end of 2025, Zylox-Tonbridge products had been used in over one million procedures, and the company had established commercial coverage in 83 countries and regions.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Zylox-Tonbridge Medical Tec","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK1587":"次新股","BK1574":"生物医药B类股","02190":"归创通桥","BK1583":"高瓴概念","BK1100":"医疗保健设备"},"translate_title":"Zylox-Tonbridge在投资者开放日展示创新渠道","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02190":0.9},"content_text":"Zylox-Tonbridge Showcases Innovation Pipeline at Investor Open Day\n    \n\n        Zylox-Tonbridge Medical Technology Co., Ltd. recently hosted an Investor Open Day at its Zhuhai Innovation Center, welcoming nearly 150 institutional investors and sell-side analysts. The event showcased the company’s innovation pipeline, including its image-guided endovascular therapy platform and the ZYLOX Pantheris™ atherectomy catheter. Management highlighted strategies for global growth, emphasizing R&D-driven innovation, global manufacturing, and expanding international commercialization. By the end of 2025, Zylox-Tonbridge products had been used in over one million procedures, and the company had established commercial coverage in 83 countries and regions.\n      \n\n\nDisclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Zylox-Tonbridge Medical Technology Co .Ltd. published the original content used to generate this news brief via PR Newswire (Ref. ID: CN60761) on January 12, 2026, and is solely responsible for the information contained therein.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"productRelease","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"hasMoreComments":false,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"isCrawlerRequest":true}